Agilent Technologies, Inc. (A)

Agilent Technologies' stock price has fluctuated between $96.43 and $160.27 over the last 52 weeks, with a closing price of $129.58 as of February 6, 2026. Key events include strong Q4 2025 results and improved FY26 guidance, although initial Q1 2026 EPS guidance was slightly below expectations. The company announced a dividend increase and participated in several healthcare conferences. Agilent launched the S540MD Slide Scanner System for digital pathology in Europe and showcased automated solutions at SLAS2026.

Specific demand seasonality information for Agilent Technologies is not readily available. However, the company anticipates increased demand after a "2023-24 reset period." Agilent experienced a downturn in China starting in Q3 2023, and the global pharmaceutical market has decelerated. There are positive signs for a potential turnaround in fiscal year 2025, with improved performance in China and initial China stimulus orders.

Agilent Technologies, Inc. is a global leader in the life sciences, diagnostics, and applied chemical markets, providing a comprehensive range of instruments, software, services, and consumables for laboratories worldwide, operating within the healthcare equipment and services sector. Agilent's products and services are crucial for life science research, patient diagnostics, and testing for water, food, and pharmaceutical safety, including automation solutions, chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and vacuum technologies. The company also provides lab management services and invests in research and development to improve workflow, efficiency, and productivity.

Headquartered in Santa Clara, California, Agilent Technologies has a significant global presence, serving customers in over 110 countries. Its worldwide network includes R&D centers, manufacturing facilities, sales offices, and customer support centers across North America, Europe, and Asia. This infrastructure supports R&D, manufacturing, direct sales, technical support, and application development.

Agilent Technologies is recognized as a global leader known for its integrity, R&D investments, scientific excellence, and customer-centricity. While there haven't been widely reported events significantly boosting its brand, Agilent's stock experienced an 11.48% decline in total shareholder return over the past year, potentially indicating a reassessment of risks and growth expectations by investors.

Agilent Technologies is primarily owned by institutional investors, with passive funds forming a stable foundation. Major institutional owners include The Vanguard Group, Inc., BlackRock, Inc., Massachusetts Financial Services Company, State Street Global Advisors, Inc., Wellington Management Group LLP, T. Rowe Price Group, Inc., Geode Capital Management, LLC, Generation Investment Management LLP, Pictet Asset Management Limited, and DWS Investment GmbH. Insider ownership is generally in the low single digits.